Loading fund overlap…
15 of 175 unique stocks in common · Jaccard: 8.6%
A weighted portfolio overlap of 9.78% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹9.78 is allocated to the exact same companies at the same relative proportions. The schemes share 15 common holdings.
The largest overlapping asset in their portfolios is Grindwell Norton, which commands a weight of 1.49% in ICICI Prudential Smallcap Fund and 1.26% in UTI - MNC Fund. Holding both schemes increases your concentration in Grindwell Norton rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in ICICI | in UTI |
|---|---|---|
| Grindwell NortonIndustrial Products | 1.49% | 1.26% |
| PfizerPharmaceuticals & Biotechnology | 1.88% | 1.08% |
| Procter & Gamble HealthPharmaceuticals & Biotechnology | 1.06% | 4.85% |
| Timken IndiaIndustrial Products | 2.25% | 1.02% |
| Gulf Oil Lubricants IndiaPetroleum Products | 0.75% | 1.16% |
| 3M IndiaDiversified | 0.73% | 1.29% |
| SKF India (Industrial)Industrial Products | 1.02% | 0.67% |
| Gillette IndiaPersonal Products | 0.94% | 0.59% |
| CIE Automotive IndiaAuto Components | 0.55% | 1.69% |
| SKF IndiaAuto Components | 1.01% | 0.50% |
| Sanofi Consumer HealthcarePharmaceuticals & Biotechnology | 0.93% | 0.43% |
| RHI Magnesita IndiaIndustrial Products | 0.37% | 1.17% |
| Astrazeneca Pharma IndiaPharmaceuticals & Biotechnology | 0.30% | 0.68% |
| Cummins IndiaIndustrial Products | 0.26% | 1.43% |
| Teamlease ServicesCommercial Services & Supplies | 0.20% | 0.70% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.